B&B Clinical Innovations Overview
- Founded
-
1976
- Status
-
Acquired/Merged
- Employees
-
130
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
B&B Clinical Innovations General Information
Description
Provider of late-stage clinical development services to pharmaceutical and biotechnology industries. The company conducts clinical trials in the fields of allergies and asthma, cardiology, gastroenterology, HIV, infectious disease dermatology, metabolic studies, oncology, osteoporosis, and urology.
Contact Information
Formerly Known As
Berger Boyer & Associates
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Acquirer
Primary Office
- 2018 Baltimore Avenue
- Kansas City, MO 64108
- United States
+1 (816) 000-0000
B&B Clinical Innovations Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
B&B Clinical Innovations Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Arthur Berger | Founder & President | ||
| Ronald Wehmeyer | Chief Financial Officer | ||
| Susan Cox | Chief Operating Officer |
B&B Clinical Innovations Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
